The Valley Desk

NCT02487979 · Interventional trial

Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma

Overall registry status Completed

Phase 2

Conditions Recurrent Osteosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov